Next-generation Sequencing: New business Models in Diagnostics and Drug Development

Aug 09th 2017

Unlocking Growth Opportunities in Molecular Diagnostics, Precision Medicine and Big-Data Analytics

Why You Must Attend:

  • Gain insights on unmet market opportunities in clinical applications of NGS.
  • Understand key challenges in the NGS space and how stakeholders plan to tackle them.
  • Participate in discussions on real case examples of how the industry is responding to these opportunities and challenges.


This site uses cookies. Cookies are used to track visitors to so we can better understand which portions of our site best serve you. This data will be used for the following purposes: Completion and support of the current activity and Web site and system administration. This data will be used only by Frost & Sullivan.